Efficacy and Safety of Vernonia Cinerea Pastilles for Smoking Cessation in Low and Moderate Nicotine Dependence

Main Article Content

Sutasinee Srisoi
Sunee Lertsinudom
Jringjai Areemit
Nadthatida Hansuri
Achara Nasatid
Nirachara Tawinka
Sineenard Pranboon
Bangorn Sripanidkulchai


Vernonia cinerea (VC) is a Thai medicinal plant that has higher efficacy for smoking cessation than placebo but the difference is not statistically significant. The previous studies have mostly focused on the 2-4 weeks treatment of various forms of VC such as infusion tea, lozenges, and capsules. Therefore, this study has developed a 12-weeks treatment with VC pastilles in smokers. Objective: To compare the efficacy of VC pastilles for smoking cessation in low and moderate nicotine dependence by measuring the continuous abstinence rate (CAR) and the 7-days prevalence abstinence rate (PAR) prior to an assessment at week 12 and the adverse events at the end of study treatment (week 12). Materials and Method: This study was a randomized, double-blind, placebo‐controlled trial of VC pastilles and placebo by block randomization technique, included intention at preparation level to quit smoking, aged 18-60 years. All of subjects received counseling to smoking cessation. The VC group received 2 pastilles; 3 times daily of 575.34 mg VC pastilles extracted from VC powder per day which reference from VC capsule study. Both groups were followed up to evaluate their smoking cessation and any adverse events at Weeks 2, 4, and 12 at the community pharmacy of the Faculty of Pharmaceutical Science, Khon Kaen University. Result: 68 subjects had low nicotine dependence (VC pastilles group: 33 subjects, control group: 35 subjects) 43 subjects had moderate nicotine dependence (VC pastilles group: 21 subjects, control group:  22 subjects). At the end of study treatment (week 12), it found that the CAR and PAR of the subjects with low nicotine dependence between the VC pastilles group and control group were 24.24% and 20.00% (OR=1.28, 95%CI: 0.41-4.04); and 36.36% and 37.14% (OR=0.97, 95%CI: 0.36-2.59) respectively. For the moderate nicotine dependence, it found that the CAR and PAR of the VC pastilles group and control group were 42.86% and 13.64% (OR=4.75, 95%CI: 1.07-21.14); and 52.38% and 22.73% (OR=3.74, 95% CI: 1.00-13.92) respectively. There was no difference of adverse events between the VC pastilles group and control group in both low and moderate nicotine dependence. Conclusion: VC pastilles has more efficacy than placebo for smoking cessation in moderated nicotine dependence, the finding has show statistic significant in CAR and PAR at week 12 so VC pastilles may be effect to nicotine dependence smoker. In addition, no serious adverse event was found.


Download data is not yet available.

Article Details

Pharmaceutical Practice


Dansakchai K, Tangjai N, Khamtat S, Seesin T, Peanchana P. Effects of quit smoking cessation clinic In the university pharmacy and Mahasarakham Hospital . IJPS 2014 Jan ; 9(Supplement):174.

Kitpaiboontawee S. Efficacy of Vernonia cinerea Lozenge as An Adjunct to Pharmacist Counseling on Smoking Abstinence Rate : A Randomized Controlled Trial. Master of Pharmacy Thesis, Clinical Pharmacy, Graduate School, Songkla University. 2012.

Leelarungrayub D. Study of Antioxidant activity and Active compounds In Leave, Flower, and Stem of Vernonia cinerea Less. Tobacco Control Research and Knowledge Management Center. 2011.

National statistical office Thailand. Survey of smoking and alcohol drinking behavior in the population of 2014. [Online]. 2016 [cited 2017 Aug 19]; Available from: http://service.nso.go.th/nso/nsopublish/themes/files/smokePocket57.pdf

Pitayarangsarit S, Chotbenjamaporn P, Punkrajang P, editors. Situation of surveillance to control tobacco consumption in Thailand. 1st ed. Tobacco Control Research and Knowledge Management Center Mahidol University: Bangkok; 2016.

Rienluek S. Cigarette smoking screening and tracking [Online]. 2016 [cited 2018 Jan 22]. Available from: http://www.mtc.or.th/pdf_que/20161.pdf

Rungruangpanya S, Guidelines for treatment of tobacco use in Thailand. In: Rungruangpanya S, Suntorntham S, editors. Tobacco Treatment In Thailand; 2012: 30-59.

The American Cancer Society medical and editorial content team. Harmful Chemicals in Tobacco Products [Online]. 2017 Apr 28 [cited 2017 Aug 19]; Available from: https://www.cancer.org/cancer/cancer-causes/tobacco-and-cancer/carcinogens-found-in-tobacco-products.html

The Royal Australian College of General Practitioners [RACGP]. Supporting smoking cessation A guide for health professionals. [cited 2017 May 13]; Available from: http://spirohub.com/wp-content/uploads/2015/12/RACGP-Supporting-smoking-cessation-A-guide-for-health-professionals.pdf

The United States Department of Health and Human Services [HHS]. Treating Tobacco Use and Dependence: 2008 Update [Online]. 2008 May [cited 2016 Feb 24]; Available form https://bphc.hrsa.gov/buckets/treatingtobacco.pdf

Tripopsakul W, Sittipunt C. Efficacy of Vernonia Cinerea for Smoking Cessation in Thai Active Smokers. Tobacco Control Research and Knowledge Management Center. 2011

Wateesatokit P. The death of Thai people per year from diseases caused by smoking [Online]. 2015 Aug 28 [cited 2017 Aug 19]. Available from: http://www.ashthailand.or.th/th/data_center_page.php?id=518

Wongwiwatthananukit S, Benjanakaskul P, Songsak T, Suwanamajo S, Verachai V. Efficacy of Vernonia Cinerea for smoking cessation. J Heal Res. 2009;23(1):31–6.

Pongpanich S. Cost of cigarettes and alcohol [Online]. 2012 May 28 [cited 2017 Sep 26]. Available from: https://thaipublica.org/2012/05/nesdb-problem-thai-social/

Keesukphan P. smoking cessation [Online]. [cited 2017 Aug 24]. Available from: http://www.thaiheart.org/images/column_1353671720/Smoking_2.pdf